2017 Pediatric Rx, Module 3- Psychotropic Medications
This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 0.75 NAPNAP contact hours, of which 0.75 is pharmacology and 0.75 related to psychopharmacology .
IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: email@example.com
Copyright 2017 © by National Association of Pediatric Nurse Practitioners (NAPNAP)
Pediatric-focused advanced practice registered nurses
- Participants will comprehend the basic mechanism of action of commonly used antidepressants and atypical antipsychotics
- Understand pharmacogenetic influences observed in response to and adverse effects associated with commonly prescribed psychotropic medications.
- Will be familiar with issues around managing or co-managing children and adolescents on antidepressants and atypical antipsychotics.
Teri Moser Woo, PhD, CPNP-BC, CNL, FAANP: Associate Dean for Graduate Nursing Programs, Pacific Lutheran University; PNP, Pediatric Urgent Care for Woodcreek Pediatrics, Puyallup, Wash.
Dr. Woo has no relevant financial relationships to disclose.
- 0.75 Contact hours